Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  401 results for ""Cystadenocarcinoma, Serous""

Your Filters

Publisher : bmj
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Molecular changes driving low-grade serous ovarian cancer and implications for treatment.

  • Authors : Kelliher L; Section of Gynecologic Oncology, University of Chicago Department of Obstetrics and Gynecology, Chicago, Illinois, USA.; Yoeli-Bik R

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Oct 07; Vol. 34 (10), pp. 1630-1638. DatePublisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Low-grade serous ovarian carcinoma: a brief overview of the histopathologic features and differential diagnosis.

Subjects: Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/pathology ; Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/diagnosis ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Jul 01; Vol. 34 (7), pp. 1109-1110. Date Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis.

  • Authors : Kim SR; Division of Gynaecologic Oncology, Princess Margaret Cancer Centre/University Health Network/Sinai Health Systems, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.; Parbhakar A

Subjects: Cytoreduction Surgical Procedures*/Cytoreduction Surgical Procedures*/Cytoreduction Surgical Procedures*/methods ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/mortality

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Jun 03; Vol. 34 (6), pp. 879-885. Date ofPublisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Management challenges in low-grade serous ovarian cancer with a BRCA mutation.

Subjects: Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics; Humans

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Apr 01; Vol. 34 (4), pp. 631-636. Date ofPublisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Low-grade versus high-grade serous ovarian cancer: comparison of surgical outcomes after secondary cytoreductive surgery.

  • Authors : Cappuccio S; Department of Women, Child and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Marchetti C

Subjects: Cytoreduction Surgical Procedures*/Cytoreduction Surgical Procedures*/Cytoreduction Surgical Procedures*/methods ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/surgery ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Feb 05; Vol. 34 (2), pp. 293-299. Date ofPublisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.

  • Authors : Kang OJ; Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Lee SW

Subjects: Peritoneal Neoplasms*/Peritoneal Neoplasms*/Peritoneal Neoplasms*/epidemiology ; Fallopian Tube Neoplasms*/Fallopian Tube Neoplasms*/Fallopian Tube Neoplasms*/pathology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Nov 06; Vol. 33 (11), pp. 1743-1749. DatePublisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Serous endometrial cancer confined to a polyp with malignant pleural effusion.

  • Authors : Mauro J; Gynecologic Oncology, Ospedale Michele e Pietro Ferrero, Verduno, Cuneo, Italy.; University of Udine, Udine, Italy.

Subjects: Pleural Effusion, Malignant* ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/pathology ; Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/pathology

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Nov 06; Vol. 33 (11), pp. 1812-1818. DatePublisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Low-grade serous ovarian cancer: expert consensus report on the state of the science.

  • Authors : Grisham RN; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA .; Slomovitz BM

Subjects: Peritoneal Neoplasms* ; Cystadenocarcinoma, Papillary* ; Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/diagnosis

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Sep 04; Vol. 33 (9), pp. 1331-1344. Date Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort study.

  • Authors : Foster KI; Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Handley KF

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology ; Peritoneal Neoplasms*/Peritoneal Neoplasms*/Peritoneal Neoplasms*/surgery ; Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/pathology

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Jun 05; Vol. 33 (6), pp. 937-943. Date ofPublisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Novel therapeutics in low-grade serous ovarian cancer.

  • Authors : Cobb L; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA .; Gershenson D

Subjects: Cystadenocarcinoma, Papillary* ; Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/drug therapy ; Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/genetics

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Mar 06; Vol. 33 (3), pp. 377-384. Date ofPublisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  401 results for ""Cystadenocarcinoma, Serous""